<DOC>
	<DOCNO>NCT01170533</DOCNO>
	<brief_summary>Clopidogrel , combination aspirin , currently recommend treatment secondary prevention ischemic event high-risk patient prevention coronary artery stent thrombosis . Patients receive aspirin clopidogrel frequently treat proton pump inhibitor , omeprazole pantoprazole , order prevent risk gastrointestinal bleeding , accord guideline . An interaction proton pump inhibitor clopidogrel suggest , may lead decrease clopidogrel effect . It remain unclear whether interaction PPIs clopidogrel might class effect may affect time regimen . The objective two-phase investigation : 1. compare clopidogrel platelet inhibitory effect take time versus separate least 8 hour omeprazole administration . 2. compare clopidogrel-induced inhibitory effect take time versus stagger least 8 hour pantoprazole administration .</brief_summary>
	<brief_title>PPI Clopidogrel Response</brief_title>
	<detailed_description>Clopidogrel , combination aspirin , currently recommend treatment secondary prevention ischemic event high-risk patient prevention coronary artery stent thrombosis . Patients receive aspirin clopidogrel frequently treat proton pump inhibitor , omeprazole pantoprazole , order prevent risk gastrointestinal bleeding , accord guideline . An interaction proton pump inhibitor clopidogrel suggest , may lead decrease clopidogrel effect . It remain unclear whether interaction PPIs clopidogrel might class effect may affect time regimen . The objective two-phase investigation : 1. compare clopidogrel platelet inhibitory effect take time versus separate least 8 hour omeprazole administration . 2. compare clopidogrel-induced inhibitory effect take time versus stagger least 8 hour pantoprazole administration . The clopidogrel dose 600mg load dose follow 75mg daily maintenance dose , start next day 7 day . Omeprazole use daily dose 40mg pantoprazole 80mg . The propose study prospective , randomize , cross-over design . Subjects randomized 1:1 fashion take PPI concomitantly ( CONC regimen ) stagger 8-12 hour ( STAG regimen ) one-week background clopidogrel therapy . In particular , CONC regimen drug take morning , STAG regimen clopidogrel take morning omeprazole evening . After 2-4 week washout period , subject crossed-over treatment regimen . After complete two treatment phase , subject undergo another washout period 2-4 week treat 1 week clopidogrel alone , without receive omeprazole therapy ( CLOP regimen ) . The sequence PPI pantoprazole prospective , randomize , cross-over design omeprazole sequence . A CLOP regimen absence pantoprazole collect enter randomization phase adequate wash-out period . Blood sample platelet function assessment perform three phase study follow time point : ) baseline , b ) 24 hour LD ( intake study medication ) , c ) 7 day ( 24 hour last MD ) .</detailed_description>
	<mesh_term>Clopidogrel</mesh_term>
	<mesh_term>Ticlopidine</mesh_term>
	<mesh_term>Pantoprazole</mesh_term>
	<mesh_term>Omeprazole</mesh_term>
	<criteria>Healthy volunteer age 18 75 year 1 . Known allergy clopidogrel omeprazole . 2 . Blood dyscrasia bleed diathesis . 3 . Recent antiplatelet treatment ( &lt; 30 day ) glycoprotein IIb/IIIa antagonist , thienopyridine ( ticlopidine , clopidogrel ) , cilostazol dipyridamole . 4 . Treatment medication may interfere CYP system ( ketoconazole , itraconazole , diltiazem , erythromycin , clarithromycin , fluvoxamine , fluoxetine , nefazodone , sertraline ) . 5 . Platelet count &lt; 100x106/microL . 6 . Diabetes mellitus 7 . History coronary artery disease , gastrointestinal bleed , gastroesophageal reflux disease ( GERD ) , cerebrovascular event active malignancy . 8 . Active bleed hemodynamic instability . 9 . Serum creatinine &gt; 2mg/dL . 10 . Baseline ALT &gt; 2.5 time upper limit normal . 11 . Pregnant female . 12 . Patients take omeprazole H2 antagonist proton pump inhibitor</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>proton pump inhibitor</keyword>
	<keyword>clopidogrel</keyword>
	<keyword>platelet function</keyword>
</DOC>